Showing results (1981-1990 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumorsM J A de Jonge, J P Droz, L Paz-Ares, et al.Investigational New Drugs|May 4, 2004
Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology GroupRussell J Schilder, John A Blessing, Michael L Pearl, et al.Investigational New Drugs|July 1, 1992
Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancerJ A Benvenuto, R A Newman, G S Bignami, et al.Investigational New Drugs|July 1, 1992
Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group StudyA Allen, M Wolf, E D Crawford, et al.Investigational New Drugs|July 1, 1992
Bis-daunomycin hydrazones: interactions with DNAD R Phillips, R T Brownlee, J A Reiss, et al.Investigational New Drugs|November 1, 1992
Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning techniqueS Urien, G Bastian, C Lucas, et al.Investigational New Drugs|November 1, 1992
Clinical pharmacology studies of oltipraz--a potential chemopreventive agentN V Dimitrov, J L Bennett, J McMillan, et al.Investigational New Drugs|November 1, 1992
Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancerM D Hauge, H J Long, L C Hartmann, et al.Investigational New Drugs|November 11, 1992
Phase II study of gemcitabine in advanced colorectal adenocarcinomaD F Moore, R Pazdur, K Daugherty, et al.Investigational New Drugs|November 1, 1992
An extended phase II trial of ifosfamide plus mesna in malignant mesotheliomaG Falkson, M Hunt, E C Borden, et al.Pageof 372